T cell recognition of donor major histocompatibility complex class Ipeptides during allograft rejection

LEW (RTI1) recipients of DA (RTIavl) skin and kidney allografts were tested for the capacity of their T lymphocytes to proliferate to three 22–24‐amino acid peptides from the hypervariable regions of the RTI‐Aavl classical MHC class I molecule. Ten days after rejecting second‐set DA kidneyallografts, spleen cells (but interestingly not lymph node cells) from LEW recipients showed strong, LEW antigen‐presenting cell‐dependent, CD4+ Tcell proliferation to peptide 1 (from the α helical region of the α1 domain). CD8+ T cells showed no response to peptide 1. There was no response by the spleen cells to peptide 2 (from the β sheet of the α2 domain) or peptide 3 (from the α helical region of the α2 domain). Immunization of LEW rats with pure RTI‐Aavl class I H chain in Freund's adjuvant gave responses identical to that seen after grafting, i.e. good CD4+ T cell proliferation to peptide 1, but none to peptides 2 and 3. However, immunization of LEW rats with peptides 1, 2 and 3 in Freund's adjuvant resulted in good CD4+ T cell proliferation responses to each of the peptides. These data demonstrate that indirect allorecognition can be stimulated by allograft rejection, and emphasize that the physiological processing of donor antigens will influence which peptides will be important in indirect allorecognition in transplantation.

[1]  P. Parham,et al.  Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule , 1990, The Journal of experimental medicine.

[2]  W. Jefferies,et al.  Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages , 1985, The Journal of experimental medicine.

[3]  P. Häyry,et al.  In situ effector mechanisms in rat kidney allograft rejection. I. Characterization of the host cellular infiltrate in rejecting allograft parenchyma. , 1979, Cellular immunology.

[4]  W. Boyle AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS , 1968, Transplantation.

[5]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[6]  R. Lechler,et al.  The question as to why major histocompatibility complex (MHC) a antigens are uniquely powerful primary immunogens and in this respect differ from antigens of the minor systems , 2003 .

[7]  F. Bach,et al.  Antigenic Requirements for Triggering of Cytotoxic T Lymphocytes , 1977, Immunological reviews.

[8]  Alan F. Williams,et al.  Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus , 1982, European journal of immunology.

[9]  J. Fabre,et al.  MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN RAT KIDNEY, URETER, AND BLADDER. LOCALIZATION WITH MONOCLONAL ANTIBODIES AND DEMONSTRATION OF Ia‐POSITIVE DENDRITIC CELLS1 , 1981, Transplantation.

[10]  B. Uitdehaag,et al.  Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages , 1990, The Journal of experimental medicine.

[11]  P. Parham,et al.  Nature of polymorphism in HLA-A, -B, and -C molecules. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Lechler,et al.  The molecular basis of alloreactivity. , 1990, Immunology today.

[13]  M. Thomsen,et al.  Corecognition of HLA-A1 and HLA-DPw3 by a human CD4+ alloreactive T lymphocyte clone , 1990, The Journal of experimental medicine.

[14]  J. Howard,et al.  Genetic control of transplant rejection. , 1982, Transplantation.

[15]  J. Fabre,et al.  Characterization of the tissue macrophage and the interstitial dendritic cell as distinct leukocytes normally resident in the connective tissue of rat heart , 1990, The Journal of experimental medicine.

[16]  D. Anderson,et al.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP , 1989, The Journal of experimental medicine.

[17]  W. McMaster,et al.  Two subsets of rat T lymphocytes defined with monoclonal antibodies , 1980, European journal of immunology.

[18]  J. Howard,et al.  The Mechanism of Graft Rejection and the Concept of Antigenic Strength , 1981, Scandinavian journal of immunology.

[19]  P. Parham,et al.  Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[21]  J. Berzofsky,et al.  Antigen Processing for Presentation to T Lymphocytes: Function, Mechanisms, and Implications for the T‐Cell Repertoire , 1988, Immunological reviews.

[22]  P. Morris,et al.  Renal Transplantation in the Rat: Details of a Technique1. , 1971, The Australian and New Zealand journal of surgery.

[23]  J. Rothbard,et al.  Peptide-mediated modulation of T-cell allorecognition. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Galfré,et al.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes , 1977, Cell.

[25]  J. Fabre,et al.  THE EFFECTS OF CYCLOSPORINE ON THE INDUCTION OF DONOR CLASS I AND CLASS II MHC ANTIGENS IN HEART AND KIDNEY ALLOGRAFTS IN THE RAT , 1986, Transplantation.

[26]  S. Hunt,et al.  A Repopulation Assay For B and T Lymphocyte Stem Cells Employing Radiation Chimaeras , 1981, Cell and tissue kinetics.

[27]  J. Fabre,et al.  Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. , 1987, Transplantation.

[28]  C. Pearson,et al.  The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT. , 1975, Immunology.

[29]  J. Fabre,et al.  Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation , 1992, European journal of immunology.

[30]  L. Brent,et al.  Presentation of alloantigens by host cells , 1986, European journal of immunology.

[31]  M. Reth,et al.  A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production , 1986, Nature.

[32]  A. Williams,et al.  Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: The quantitative analysis of a xenogeneic antiserum , 1975, European journal of immunology.

[33]  M. Bevan,et al.  High determinant density may explain the phenomenon of alloreactivity. , 1984, Immunology today.